| Bantu Samridhi Chhangani, MD | |
|
1500 S Lake Park Ave, Hobart, IN 46342 | |
| (219) 942-0551 | |
| Not Available |
| Full Name | Bantu Samridhi Chhangani |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 24 Years |
| Location | 1500 S Lake Park Ave, Hobart, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114198223 | NPI | - | NPPES |
| 1114198223 | Medicaid | MI |
| Facility Name | Location | Facility Type |
|---|---|---|
| Rush Oak Park Hospital | Oak park, IL | Hospital |
| St Mary Medical Center Inc | Hobart, IN | Hospital |
| Rush University Medical Center | Chicago, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Community Care Network Inc | 3678737012 | 360 |
| Rush University Medical Center | 5496658874 | 1007 |
News Archive
The Multiple Sclerosis Research Center of New York (MSRCNY), together with the International Multiple Sclerosis Management Practice (IMSMP), today announced that results from its Intrathecal Methotrexate Treatment in Multiple Sclerosis study have been published in this month's issue of Journal of Neurology. This study reports on the feasibility of using intrathecal methotrexate (ITMTX) in treatment unresponsive multiple sclerosis (MS) patients with progressive forms of the disease.
A leading mental health expert from Kingston University and St George's, University of London has called for greater international research collaboration to underpin the care offered to support severely disturbed people.
Repligen Corporation has announced that it has exclusively licensed worldwide rights for the use of uridine in the treatment of patients with bipolar disorder from McLean Hospital.
In a small study published in the medRxiv* preprint server, people given a booster Johnson & Johnson COVID-19 shot showed elevated and robust antibody levels.
› Verified 5 days ago
| Entity Name | Apogee Medical Group Indiana Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093973885 PECOS PAC ID: 8729155742 Enrollment ID: O20080917000320 |
News Archive
The Multiple Sclerosis Research Center of New York (MSRCNY), together with the International Multiple Sclerosis Management Practice (IMSMP), today announced that results from its Intrathecal Methotrexate Treatment in Multiple Sclerosis study have been published in this month's issue of Journal of Neurology. This study reports on the feasibility of using intrathecal methotrexate (ITMTX) in treatment unresponsive multiple sclerosis (MS) patients with progressive forms of the disease.
A leading mental health expert from Kingston University and St George's, University of London has called for greater international research collaboration to underpin the care offered to support severely disturbed people.
Repligen Corporation has announced that it has exclusively licensed worldwide rights for the use of uridine in the treatment of patients with bipolar disorder from McLean Hospital.
In a small study published in the medRxiv* preprint server, people given a booster Johnson & Johnson COVID-19 shot showed elevated and robust antibody levels.
› Verified 5 days ago
| Entity Name | Community Care Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457610487 PECOS PAC ID: 3678737012 Enrollment ID: O20120614000331 |
News Archive
The Multiple Sclerosis Research Center of New York (MSRCNY), together with the International Multiple Sclerosis Management Practice (IMSMP), today announced that results from its Intrathecal Methotrexate Treatment in Multiple Sclerosis study have been published in this month's issue of Journal of Neurology. This study reports on the feasibility of using intrathecal methotrexate (ITMTX) in treatment unresponsive multiple sclerosis (MS) patients with progressive forms of the disease.
A leading mental health expert from Kingston University and St George's, University of London has called for greater international research collaboration to underpin the care offered to support severely disturbed people.
Repligen Corporation has announced that it has exclusively licensed worldwide rights for the use of uridine in the treatment of patients with bipolar disorder from McLean Hospital.
In a small study published in the medRxiv* preprint server, people given a booster Johnson & Johnson COVID-19 shot showed elevated and robust antibody levels.
› Verified 5 days ago
| Entity Name | 24 On Physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205186715 PECOS PAC ID: 5698688141 Enrollment ID: O20130423000335 |
News Archive
The Multiple Sclerosis Research Center of New York (MSRCNY), together with the International Multiple Sclerosis Management Practice (IMSMP), today announced that results from its Intrathecal Methotrexate Treatment in Multiple Sclerosis study have been published in this month's issue of Journal of Neurology. This study reports on the feasibility of using intrathecal methotrexate (ITMTX) in treatment unresponsive multiple sclerosis (MS) patients with progressive forms of the disease.
A leading mental health expert from Kingston University and St George's, University of London has called for greater international research collaboration to underpin the care offered to support severely disturbed people.
Repligen Corporation has announced that it has exclusively licensed worldwide rights for the use of uridine in the treatment of patients with bipolar disorder from McLean Hospital.
In a small study published in the medRxiv* preprint server, people given a booster Johnson & Johnson COVID-19 shot showed elevated and robust antibody levels.
› Verified 5 days ago
| Entity Name | Northwest Hospitalist Physicians, Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023448321 PECOS PAC ID: 0244397693 Enrollment ID: O20140205000078 |
News Archive
The Multiple Sclerosis Research Center of New York (MSRCNY), together with the International Multiple Sclerosis Management Practice (IMSMP), today announced that results from its Intrathecal Methotrexate Treatment in Multiple Sclerosis study have been published in this month's issue of Journal of Neurology. This study reports on the feasibility of using intrathecal methotrexate (ITMTX) in treatment unresponsive multiple sclerosis (MS) patients with progressive forms of the disease.
A leading mental health expert from Kingston University and St George's, University of London has called for greater international research collaboration to underpin the care offered to support severely disturbed people.
Repligen Corporation has announced that it has exclusively licensed worldwide rights for the use of uridine in the treatment of patients with bipolar disorder from McLean Hospital.
In a small study published in the medRxiv* preprint server, people given a booster Johnson & Johnson COVID-19 shot showed elevated and robust antibody levels.
› Verified 5 days ago
| Entity Name | Hospitalist Physicians Of Indiana Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306576277 PECOS PAC ID: 1052795986 Enrollment ID: O20220826000967 |
News Archive
The Multiple Sclerosis Research Center of New York (MSRCNY), together with the International Multiple Sclerosis Management Practice (IMSMP), today announced that results from its Intrathecal Methotrexate Treatment in Multiple Sclerosis study have been published in this month's issue of Journal of Neurology. This study reports on the feasibility of using intrathecal methotrexate (ITMTX) in treatment unresponsive multiple sclerosis (MS) patients with progressive forms of the disease.
A leading mental health expert from Kingston University and St George's, University of London has called for greater international research collaboration to underpin the care offered to support severely disturbed people.
Repligen Corporation has announced that it has exclusively licensed worldwide rights for the use of uridine in the treatment of patients with bipolar disorder from McLean Hospital.
In a small study published in the medRxiv* preprint server, people given a booster Johnson & Johnson COVID-19 shot showed elevated and robust antibody levels.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bantu Samridhi Chhangani, MD 205 Oak Tree Ct, Palos Park, IL 60464-1978 Ph: (708) 408-1101 | Bantu Samridhi Chhangani, MD 1500 S Lake Park Ave, Hobart, IN 46342 Ph: (219) 942-0551 |
News Archive
The Multiple Sclerosis Research Center of New York (MSRCNY), together with the International Multiple Sclerosis Management Practice (IMSMP), today announced that results from its Intrathecal Methotrexate Treatment in Multiple Sclerosis study have been published in this month's issue of Journal of Neurology. This study reports on the feasibility of using intrathecal methotrexate (ITMTX) in treatment unresponsive multiple sclerosis (MS) patients with progressive forms of the disease.
A leading mental health expert from Kingston University and St George's, University of London has called for greater international research collaboration to underpin the care offered to support severely disturbed people.
Repligen Corporation has announced that it has exclusively licensed worldwide rights for the use of uridine in the treatment of patients with bipolar disorder from McLean Hospital.
In a small study published in the medRxiv* preprint server, people given a booster Johnson & Johnson COVID-19 shot showed elevated and robust antibody levels.
› Verified 5 days ago
Maali Milhem, MBBS Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1354 S Lake Park Ave, Hobart, IN 46342 Phone: 219-945-5888 Fax: 219-945-5880 | |
Javairia Quraishi, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1500 S Lake Park Ave, Hobart, IN 46342 Phone: 219-945-4580 Fax: 219-945-4581 | |
Abdul Tamim Ward, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 1500 S Lake Park Ave, Hobart, IN 46342 Phone: 055-121-9942 | |
Dr. May Y. Lee, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7875 Grand Blvd, Pulmonary Specialists Of Northwest Indiana, Pc, Hobart, IN 46342 Phone: 219-942-9658 Fax: 219-947-1996 | |
Denise C Weaver, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1400 S Lake Park Ave Ste 304, Hobart, IN 46342 Phone: 219-947-6638 Fax: 219-703-6693 | |
Milton Stanley Gasparis, MD PHD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1352 S Lake Park Ave, Hobart, IN 46342 Phone: 219-942-7244 Fax: 219-942-0975 |